Supernus Pharmaceuticals (SUPN) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

SUPN is expected to report earnings to fall 43.44% to 43 cents per share on November 05

Supernus Pharmaceuticals SUPN Stock Earnings Reports

Q3'24

Est.

$0.43

Q2'24

Beat

by $0.37

Q1'24

Missed

by $0.38

Q4'23

Missed

by $0.54

Q3'23

Missed

by $0.31

The last earnings report on August 06 showed earnings per share of 76 cents, beating the estimate of 38 cents. With 271.18K shares outstanding, the current market capitalization sits at 1.84B.

View a ticker or compare two or three

Compare

SUPN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SUPN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for SUPN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

9715 Key West Avenue

Phone

+1 301 838-2500

Employees

652

Web

https://www.supernus.com